trending Market Intelligence /marketintelligence/en/news-insights/trending/jx_alynw7eq-yctmgbp9dg2 content esgSubNav
In This List

Sinco Pharmaceuticals Holdings directors retire

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Sinco Pharmaceuticals Holdings directors retire

Sinco Pharmaceuticals Holdings Ltd. said two directors were not re-elected and retired from the company's board.

Shareholders did not re-elect Chen David Yu and Philip Wong Yee Teng as independent nonexecutive directors at the company's May 25 annual general meeting.

Sinco Pharmaceuticals, which provides promotion and channel management services to China's pharmaceutical industry, added Chen and Wong to its board in January.

The company said it is not aware of any disagreement with the directors regarding their retirement.